Fees & payments You are here:HomeResearch & EducationResearch OfficeFees & payments Fees are payable in FULL at the time of submission for the following: New Research Projects for HREC Review (commercially sponsored and collaborative studies) Research Projects for Site Specific Assessment (SSA) Review (commercially sponsored and collaborative studies) Amendments to Approved Research Projects (commercially sponsored studies) Please contact the Research Office by email at SVHS.research@svha.org.au for a Fee Payment Reference Number (FPR) prior to making your submission. Please Note: Credit Card payments are the preferred method of payment The Research Office does not accept payment by cheque Invoice requests for payment by EFT can take up to three weeks to process All submission review fees are in accordance with NSW Health Fee Policy Guidelines Pay online by credit card > HREC REVIEW FEES 2015 Inc GST Submissions to the Full HREC Investigator-initiated research projects within St Vincent’s Hospital, St Vincent's Private Hospital or The Mater Hospital, Sydney No fee Cooperative/collaborative group research project without commercial sponsorship $150 External research projects without commercial sponsorship (eg. university and external entities) $150 Commercially sponsored research project $3300 Any collaborative-type study with commercial sponsorship $3300 Low/Negligible Risk (LNR) Projects Investigator-initiated research projects within St Vincent’s Hospital, St Vincent's Private Hospital or The Mater Hospital, Sydney No fee Cooperative/collaborative group research project without commercial sponsorship Please Note: For studies with commercial support (eg. unrestricted educational grants) this fee only applies when the commercial body has no ownership of the study data. $100 External research projects without commercial sponsorship (eg. university and external entities) Please Note: For studies with commercial support (eg. unrestricted educational grants) this fee only applies when the commercial body has no ownership of the study data. $100 Commercially sponsored research project $3300 Amendments to Approved Research Projects Investigator-initiated research projects within St Vincent’s Hospital, St Vincent's Private Hospital or The Mater Hospital, Sydney No fee Cooperative/collaborative group research project without commercial sponsorship No fee Commercially sponsored research projects Please Note: Fees are applied to each version change to Investigator's Brochures (or equivalent) and/or Protocol document (or equivalent). For example, if you would like to amend both the Investigator’s Brochure and the Protocol, the fee will be $550 +$550= $1100. Note that amendment fees do not apply to minor administrative changes. $550 Substantial amendments to commercially sponsored research projects (e.g.changes in study design; please contact the Research Office if you are unsure about your amendment submission type) $1665 RESEARCH GOVERNANCE FEES 2015 Site Specific Assessment (SSA) Review Investigator-initiated research projects within St Vincent’s Hospital, St Vincent's Private Hospital or The Mater Hospital, Sydney No fee Cooperative/collaborative/external (e.g. universities) group research projects without commercial sponsorship $250 Commercially sponsored research projects $3740 Any collaborative-type study with commercial sponsorship $3740 SSA Review for Low/Negligible Risk (LNR) studies Investigator-initiated research projects within St Vincent’s Hospital, St Vincent's Private Hospital or The Mater Hospital, Sydney No fee Cooperative/collaborative/external (e.g. universities) group research projects without commercial sponsorship $75 Commercially sponsored research projects $3740 Any collaborative-type study with commercial sponsorship $3740 STUDY DEFINITIONS: St Vincent’s Hospital Sydney has adopted the definitions from VMIA Managed Insurance ‘Guidelines for Clinical Trials’ (2009): Investigator Initiated Research: An investigator initiated research project has the following characteristics: A pharmaceutical/device company is not acting as the Sponsor for the purposes of the CTN Scheme application A pharmaceutical/device company is not directly funding the conduct of the study, that is making payment to the relevant hospital or investigator The clinical trial addresses relevant clinical questions and not industry needs The Principal Investigator or the Hospital/Institution is the primary author and custodian of the clinical trial protocol Note – Investigator initiated trials can receive some industry funding or industry contribution, (e.g. educational grants, or supply of medication). However, the support must be declared in the protocol submission, to ensure that the clinical trial retain its “investigator initiated” status. Commercially Sponsored Research: A commercially sponsored research project has the following characteristics: It is initiated by a pharmaceutical/device company or other commercial entity and not by an investigator at a NSW public health service site The research is conducted to investigate a medication/device for commercial exploitation by its manufacturer/sponsor The protocol has been developed and is the responsibility of a pharmaceutical/device company or other commercial entity Co-operative/Collaborative Research: Co-operative/Collaborative Research has the following characteristics: The research must address relevant clinical questions and not pharmaceutical/device industry or commercial needs. The co-operative group must declare the nature of any sponsorship from a pharmaceutical entity or any other entity that may directly benefit commercially from the research outcomes. The co-operative group must be the primary author and custodian of the clinical trial protocol. Infrastructure Fee: St. Vincent's Hospital charges an infrastructure fee on all research projects. Infrastructure charges relate to those that cannot be identified readily (or specifically) with a particular sponsored project. These include maintaining and operating the Hospital's facilities and services including, but not limited to: Clinical, laboratory and office space to conduct research and clinical trials activities; Utilities including water, electricity, heating, gas and air conditioning; Corporate support services including accounting, purchasing, payroll, human resources and legal counsel.